financetom
Business
financetom
/
Business
/
Blackstone's International Gemmological Institute Reportedly Files for IPO in India
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Blackstone's International Gemmological Institute Reportedly Files for IPO in India
Aug 25, 2024 12:30 PM

11:27 AM EDT, 08/22/2024 (MT Newswires) -- Blackstone-owned (BX) International Gemmological Institute has filed for an initial public offering of up to 40 billion rupees, or $476.5 million, in India, according to news reports on Thursday.

Blackstone will sell up to 27.5 billion rupees worth of shares in IGI, which grades diamonds, gemstones and jewelry, Reuters reported, citing a regulatory filing.

IGI will offer new shares worth up to 12.5 billion rupees, the report said.

Blackstone will use the proceeds for payments related to acquisitions in IGI Belgium and IGI Netherlands, the report said.

Blackstone and IGI did not immediately reply to MT Newswires' request for comment.

Price: 133.97, Change: -0.78, Percent Change: -0.58

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Regeneron to defend US Justice Department's complaint on drug-pricing manipulation
Regeneron to defend US Justice Department's complaint on drug-pricing manipulation
Apr 15, 2024
(Reuters) - Regeneron Pharmaceuticals ( REGN ) said on Monday the U.S. Justice Department's complaint against the company misreporting the average sales price for its macular degeneration drug Eylea is meritless and it plans to defend this case in court. The Justice Department last week had accused Regeneron of manipulating Medicare's drug-pricing process by inflating the average sales price for...
Regeneron to defend against DOJ complaint on drug-price manipulation
Regeneron to defend against DOJ complaint on drug-price manipulation
Apr 15, 2024
April 15 (Reuters) - Regeneron Pharmaceuticals ( REGN ) said on Monday it seeks to defend against U.S. Department of Justice's complaint that alleged the company misreported the average sales price of its macular degeneration drug Eylea. Reimbursing credit card service fees to distributors is not a price concession and does not affect EYLEA's price, Regeneron said in a statement,...
MercadoLibre to hire 6,500 people in Brazil in 2024
MercadoLibre to hire 6,500 people in Brazil in 2024
Apr 15, 2024
SAO PAULO, April 15 (Reuters) - Latin American e-commerce giant MercadoLibre ( MELI ) is planning to hire 6,500 people in Brazil this year, President Luiz Inacio Lula da Silva's office said on Monday, after he met with the firm's top executive in the country. That would increase MercadoLibre's ( MELI ) staff in Brazil, its main market, by 28%...
Regeneron to defend US Justice Department's complaint on drug-pricing manipulation
Regeneron to defend US Justice Department's complaint on drug-pricing manipulation
Apr 15, 2024
April 15 (Reuters) - Regeneron Pharmaceuticals ( REGN ) said on Monday the U.S. Justice Department's complaint against the company misreporting the average sales price for its macular degeneration drug Eylea is meritless and it plans to defend this case in court. The Justice Department last week had accused Regeneron of manipulating Medicare's drug-pricing process by inflating the average sales...
Copyright 2023-2026 - www.financetom.com All Rights Reserved